Vaccitech
company in Oxford, United Kingdom
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people.
Vaccitech’s social media accounts
Social
Web
2 external identifiers
Something wrong with this entry? Report it · How corrections work
Last updated · Handles last checked · How we check